Investigation of Nyxoah S.A. by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses.

LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm has announced that it is investigating Nyxoah S.A. ("Nyxoah" or "the Company") for potential securities fraud that may harm investors of NYXH. Those who have incurred losses while investing in Nyxoah are strongly encouraged to reach out to Lesley Portnoy, Esq.

Investors wishing to explore their legal rights may contact attorney Lesley F. Portnoy at 310-692-8883 or via email at [email protected] for a discussion. They can also click here to participate in the case. The Portnoy Law Firm offers a no-obligation case evaluation to help investors understand their options for recovering losses.

Just a few days ago, specifically on March 25, 2025, Nyxoah made a significant announcement regarding its Genio® system. The U.S. Food and Drug Administration (FDA) had issued an Approvable Letter for the company's Pre-Market Approval (PMA) application, indicating that the application met substantial regulatory criteria. However, final approval is contingent upon a successful review of the company's manufacturing practices and facilities.

This news sparked concerns among analysts, who predict a delay in the commercial launch of Genio due to the required additional FDA review.

In response to this announcement, Nyxoah's stock price experienced a notable drop of $2.42 per share, which translates to a decline of 21.36%, closing at $8.91 on March 26, 2025.

For more details and to share transaction information, investors are encouraged to visit the law firm's website.

The Portnoy Law Firm specializes in representing investors in claims arising from corporate misconduct. The firm’s founding partner has successfully recovered over $5.5 billion on behalf of aggrieved investors. Note that prior results do not guarantee similar outcomes.

Attorney Advertising.

investigation, securities, losses